By Aaron Biros| 2019-10-30T16:30:18+00:00 October 30th, 2019|analysis, analytics, brand, Brexit, Britain, British, business, Business Analysis, canada, cannabis, cbd, certificate, certification, certify, climate, compliance, consumer, cultivation, Danish, Denmark, dispensary, Dutch, economic, economically, EU, europe, European, export, extraction, Federal, German, Germany, GMP, government, Greece, growing, import, industry, international, invest investment, Italy, law, legal, legalization, legalize, legislation, license, Macedonia, malta, marijuana, market, medical, medicine, Netherland, Netherlands, Operations, Poland, political, politics, Portugal, product, Product Development, production, Quality, recreational, regulation, regulations, Regulatory, retail, safety, spain, state, test, thc, uk, Union, United Kingdom, wage|0 Comments
Coalition of organizations come together to provide medical cannabis to patients as part of nationwide pilot
The post UK Non-Profit Launches Project TWENTY21 To Register 20K Cannabis Patients appeared first on Cannabis Industry Journal.
A group of investors, established companies, start-ups, lobbying groups, patient activists and doctors are descending on London for the first ever European Cannabis Week, June 23-29
The post European Cannabis Week Kicks Off First Year In London appeared first on Cannabis Industry Journal.
New international trade agreements on pharmaceutical quality and inspection are a big driver for the map of the modern cannabis industry globally.
The post Why International Trade Agreements Are Shaping The Cannabis Industry appeared first on Cannabis Industry Journal.
Those already confused about the "novel food" designation given to cannabis-sourced CBD have a new champion as hemp extracts fall under the same rules per the EU.
The post British Barristers Take On Cannabis “Novel Food” Regulation In Brussels appeared first on Cannabis Industry Journal.